Clinical Trials Logo

Clinical Trial Summary

Current recommendations do not recommend the concomitant administration of albumin after ascites puncture in patients with ascites neoplasia unlike cirrhotic ascites. The etiology of ascites in cancer patients is multifactorial, particularly by hepatic invasion that can lead to ascites loaded with albumin. Ascites punctures therefore lead to undernutrition, recurrent early ascites by decreasing the oncotic pressure by hypo albuminemia and a state of anasarca affecting the quality of life.


Clinical Trial Description

According to the recommendations, each ascites fluid must be sent for biochemical and bacteriological analysis.

Demonstrate the high gradient proportion (percent only, no threshold of significance required). The literature has already validated the importance of supplementing albumen with cirrhotic ascites. Demonstrating that some cancer patients have high gradients, this will be enough to make the practitioner think to supplement. ;


Study Design


Related Conditions & MeSH terms

  • Ascites
  • Solid Cancer in a Palliative Situation With Ascites

NCT number NCT03463655
Study type Observational
Source Institut Paoli-Calmettes
Contact Aurélien PROUX
Phone 0491227643
Email PROUXA@ipc.unicancer.fr
Status Recruiting
Phase N/A
Start date December 21, 2017
Completion date April 2018